Over-expression of adenosine deaminase in mouse podocytes does not reverse puromycin aminonucleoside resistance

BMC Nephrology

Volumn 11, Issue 1, 2010, Pages

  Brideau, Gaëlle ^a   Doucet, Alain ^a  

^a SORBONNE UNIVERSITÉ   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE DEAMINASE; MESSENGER RNA; PROTEIN; PUROMYCIN AMINONUCLEOSIDE; SODIUM; ADA PROTEIN, MOUSE; ADA PROTEIN, RAT; HYBRID PROTEIN; MEMBRANE PROTEIN; NEPHRIN; PODOCIN; SIGNAL PEPTIDE; SYNTHETIC DNA;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG RESISTANCE; GLOMERULUS; MALE; MOUSE; NONHUMAN; PODOCYTE; PROTEIN EXPRESSION; PROTEINURIA; RAT; TRANSGENICS; URINARY EXCRETION; ANIMAL; BIOSYNTHESIS; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; EDEMA; ENZYME INDUCTION; ENZYMOLOGY; GENETICS; NATRIURESIS; NEPHROTIC SYNDROME; PHYSIOLOGY; PROMOTER REGION; SPECIES DIFFERENCE; TRANSGENIC MOUSE;

ADENOSINE DEAMINASE; ANIMALS; DRUG RESISTANCE; EDEMA; ENZYME INDUCTION; GENES, SYNTHETIC; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; KIDNEY GLOMERULUS; MEMBRANE PROTEINS; MICE; MICE, TRANSGENIC; NATRIURESIS; NEPHROTIC SYNDROME; PODOCYTES; PROMOTER REGIONS, GENETIC; PROTEINURIA; PUROMYCIN AMINONUCLEOSIDE; RATS; RECOMBINANT FUSION PROTEINS; RNA, MESSENGER; SPECIES SPECIFICITY;

EID: 77954812403     PISSN: None     EISSN: 14712369     Source Type: Journal    
DOI: 10.1186/1471-2369-11-15     Document Type: Article

References (44)

1. Molecular mechanism of edema formation in nephrotic syndrome: therapeutic implications. A Doucet G Favre G Deschenes, Pediatr Nephrol 2007 22 12 1983 1990 10.1007/s00467-007-0521-3 17554565
2. Experimental nephrotic syndrome induced in rats by aminonucleoside; renal lesions and body electrolyte composition. S Frenk I Antonowicz JM Craig J Metcoff, Proc Soc Exp Biol Med 1955 89 3 424 427 13254783
3. Pathophysiology of experimental nephrotic syndrome induced by puromycin aminonucleoside in rats. I. The role of proteinuria, hypoproteinemia, and renin-angiotensin-aldosterone system on sodium retention. J Pedraza-Chaverri C Cruz ME Ibarra-Rubio MT Chavez C Calleja E Tapia M del Carmen Uribe L Romero JC Pena, Rev Invest Clin 1990 42 1 29 38 2236972 (Pubitemid 20284913)
4. Collecting duct is a site of sodium retention in PAN nephrosis: a rationale for amiloride therapy. G Deschenes M Wittner A Stefano S Jounier A Doucet, J Am Soc Nephrol 2001 12 3 598 601 11181809
5. Role for intrarenal mechanisms in the impaired salt excretion of experimental nephrotic syndrome. I Ichikawa HG Rennke JR Hoyer KF Badr N Schor JL Troy CP Lechene BM Brenner, J Clin Invest 1983 71 1 91 103 10.1172/JCI110756 6848563
6. Hyperaldosteronemia and activation of the epithelial sodium channel are not required for sodium retention in puromycin-induced nephrosis. S Lourdel J Loffing G Favre M Paulais A Nissant P Fakitsas C Creminon E Feraille F Verrey J Teulon, et al. J Am Soc Nephrol 2005 16 12 3642 3650 10.1681/ASN.2005040363 16267158
7. Blunted excretory response to atrial natriuretic peptide in experimental nephrosis. N Perico F Delaini C Lupini A Benigni M Galbusera P Boccardo G Remuzzi, Kidney Int 1989 36 1 57 64 10.1038/ki.1989.161 2554049
8. Renal response to atrial natriuretic peptide in nephrotic syndrome. AJ Rabelink HA Koomans CA Gaillard EJ Dorhout Mees, Nephrol Dial Transplant 1987 2 6 510 514 2964567
9. Collecting duct (Na+/K+)-ATPase activity is correlated with urinary sodium excretion in rat nephrotic syndromes. G Deschenes A Doucet, J Am Soc Nephrol 2000 11 4 604 615 10752519
10. Sodium-independent in vitro induction of Na+,K+-ATPase by aldosterone in renal target cells: permissive effect of triiodothyronine. C Barlet-Bas C Khadouri S Marsy A Doucet, Proc Natl Acad Sci USA 1988 85 5 1707 1711 10.1073/pnas.85.5.1707 2830627
11. Aldosterone-mediated regulation of ENaC alpha, beta, and gamma subunit proteins in rat kidney. S Masilamani GH Kim C Mitchell JB Wade MA Knepper, J Clin Invest 1999 104 7 19 23 10.1172/JCI7840 10510339
12. Increased expression but not targeting of ENaC in adrenalectomized rats with PAN-induced nephrotic syndrome. S de Seigneux SW Kim SC Hemmingsen J Frokiaer S Nielsen, Am J Physiol Renal Physiol 2006 291 1 208 217 10.1152/ajprenal.00399.2005 16403831
13. An adenosine deaminase inhibitor prevents puromycin aminonucleoside nephrotoxicity. K Nosaka T Takahashi T Nishi H Imaki T Suzuki K Suzuki K Kurokawa H Endou, Free Radic Biol Med 1997 22 4 597 605 10.1016/S0891-5849(96) 00349-8 9013123
14. Podocyte-specific expression of organic cation transporter PMAT: implication in puromycin aminonucleoside nephrotoxicity. L Xia M Zhou TF Kalhorn HT Ho J Wang, Am J Physiol Renal Physiol 2009 296 6 1307 1313 10.1152/ajprenal.00046.2009 19357181
15. Proteinase-activated receptor 2 stimulates Na,K-ATPase and sodium reabsorption in native kidney epithelium. L Morla G Crambert D Mordasini G Favre A Doucet M Imbert-Teboul, J Biol Chem 2008 283 42 28020 28028 10.1074/jbc.M804399200 18678869
16. Developmental expression of adenosine deaminase in the upper alimentary tract of mice. JM Chinsky V Ramamurthy WC Fanslow DE Ingolia MR Blackburn KT Shaffer HR Higley JJ Trentin FB Rudolph TB Knudsen, et al. Differentiation 1990 42 3 172 183 10.1111/j.1432-0436.1990.tb00759.x 2187728
17. The distribution of adenosine deaminase among lymphocyte populations in the rat. R Barton F Martiniuk R Hirschhorn I Goldschneider, J Immunol 1979 122 1 216 220 310828
18. Tissue compartment analysis for biomarker discovery by gene expression profiling. A Disset L Cheval O Soutourina JP Duong Van Huyen G Li C Genin J Tostain A Loupy A Doucet R Rajerison, PLoS One 2009 4 11 7779 10.1371/journal.pone.0007779 19901995
19. A panoramic view of gene expression in the human kidney. D Chabardes-Garonne A Mejean JC Aude L Cheval A Di Stefano MC Gaillard M Imbert-Teboul M Wittner C Balian V Anthouard, et al. Proc Natl Acad Sci USA 2003 100 23 13710 13715 10.1073/pnas.2234604100 14595018
20. Transgenic mice expressing nitroreductase gene under the control of the podocin promoter: a new murine model of inductible glomerular injury. G Macary J Rossert P Bruneval C Mandet MF Belair P Houillier JP Van Huyen, Virchows Arch 456 3 325 337 10.1007/s00428-009-0840-9 19806361
21. The role of superoxide anion and hydrogen peroxide in glomerular injury induced by puromycin aminonucleoside in rats. M Beaman R Birtwistle AJ Howie J Michael D Adu, Clin Sci (Lond) 1987 73 3 329 332 2820648
22. Reactive oxygen species and antioxidant defense in puromycin aminonucleoside glomerulopathy. W Gwinner U Landmesser RP Brandes B Kubat J Plasger O Eberhard KM Koch CJ Olbricht, J Am Soc Nephrol 1997 8 11 1722 1731 9355075
23. Increased oxidative stress and apoptosis in acute puromycin aminonucleoside nephrosis. J Rincon M Romero N Viera A Pedreanez J Mosquera, Int J Exp Pathol 2004 85 1 25 33 10.1111/j.0959-9673.2004.0368.x 15113391
24. A role for oxygen free radicals in aminonucleoside nephrosis. JR Diamond JV Bonventre MJ Karnovsky, Kidney Int 1986 29 2 478 483 10.1038/ki.1986.24 3702206
25. Evidence suggesting a role for hydroxyl radical in puromycin aminonucleoside-induced proteinuria. V Thakur PD Walker SV Shah, Kidney Int 1988 34 4 494 499 10.1038/ki.1988.208 2848972
26. Metabolism of aminonucleoside-8-14C in the rat and guinea pig. HT Nagasawa KF Swingle CS Alexander, Biochem Pharmacol 1967 16 11 2211 2219 10.1016/0006-2952(67)90020-2 6076611
27. Deletion of CD151 results in a strain-dependent glomerular disease due to severe alterations of the glomerular basement membrane. RM Baleato PL Guthrie MC Gubler LK Ashman S Roselli, Am J Pathol 2008 173 4 927 937 10.2353/ajpath.2008.071149 18787104
28. Proteinuria of nonautoimmune origin in wild-type FVB/NJ mice. SM Maier JK Gross KL Hamlin JL Maier JL Workman XR Kim-Howard TR Schoeb AD Farris, Comp Med 2007 57 3 255 266 17605340
29. Puromycin induces reversible proteinuric injury in transgenic mice expressing cyclooxygenase-2 in podocytes. YI Jo H Cheng S Wang GW Moeckel RC Harris, Nephron Exp Nephrol 2007 107 3 87 94 10.1159/000108653 17890881
30. Hypercholesterolemia is a prerequisite for puromycin inducible damage in mouse kidney. ZZ Cheng A Patari K Aalto-Setala D Novikov D Schlondorff H Holthofer, Kidney Int 2003 63 1 107 112 10.1046/j.1523-1755.2003.00726.x 12472773
31. Aminonucleoside nephrosis in PRO/Re mice. YS Kanwar JR Manaligod CA Krakower, Proc Soc Exp Biol Med 1977 155 3 339 345 877132
32. Maintenance of Glomerular Filtration Barrier Integrity Requires Laminin {alpha}5. S Goldberg TL Adair-Kirk RM Senior JH Miner, J Am Soc Nephrol
33. The renal glomerulus of mice lacking s-laminin/laminin beta 2: nephrosis despite molecular compensation by laminin beta 1. PG Noakes JH Miner M Gautam JM Cunningham JR Sanes JP Merlie, Nat Genet 1995 10 4 400 406 10.1038/ng0895-400 7670489
34. Mice deficient in alpha-actinin-4 have severe glomerular disease. CH Kos TC Le S Sinha JM Henderson SH Kim H Sugimoto R Kalluri RE Gerszten MR Pollak, J Clin Invest 2003 111 11 1683 1690 10.1172/JCI17988 12782671
35. Congenital nephrotic syndrome in mice lacking CD2-associated protein. NY Shih J Li V Karpitskii A Nguyen ML Dustin O Kanagawa JH Miner AS Shaw, Science 1999 286 5438 312 315 10.1126/science.286.5438.312 10514378
36. Podocin inactivation in mature kidneys causes focal segmental glomerulosclerosis and nephrotic syndrome. G Mollet J Ratelade O Boyer AO Muda L Morisset TA Lavin D Kitzis MJ Dallman L Bugeon N Hubner, et al. J Am Soc Nephrol 2009 20 10 2181 2189 10.1681/ASN.2009040379 19713307
37. A humanized mouse model of idiopathic nephrotic syndrome suggests a pathogenic role for immature cells. AL Sellier-Leclerc A Duval S Riveron MA Macher G Deschenes C Loirat MC Verpont M Peuchmaur P Ronco RC Monteiro, et al. J Am Soc Nephrol 2007 18 10 2732 2739 10.1681/ASN.2006121346 17855645
38. Adriamycin-induced nephrotic syndrome in rats: sequence of pathologic events. T Bertani A Poggi R Pozzoni F Delaini G Sacchi Y Thoua G Mecca G Remuzzi MB Donati, Lab Invest 1982 46 1 16 23 6172662
39. The alternative pathway of complement is activated in the glomeuli and tubulointerstitium of mice with adriamycin nephropathy. AM Lenderink K Liegel D Ljubanovic KE Coleman GS Gilkeson VM Holers JM Thurman, Am J Physiol Renal Physiol 2007 293 2 555 564 10.1152/ajprenal.00403.2006 17522263
40. A Mendelian locus on chromosome 16 determines susceptibility to doxorubicin nephropathy in the mouse. Z Zheng KM Schmidt-Ott S Chua KA Foster RZ Frankel P Pavlidis J Barasch VD D'Agati AG Gharavi, Proc Natl Acad Sci USA 2005 102 7 2502 2507 10.1073/pnas.0409786102 15699352
41. Distinct roles for basal and induced COX-2 in podocyte injury. H Cheng X Fan Y Guan GW Moeckel R Zent RC Harris, J Am Soc Nephrol 2009 20 9 1953 1962 10.1681/ASN.2009010039 19643929
42. CCR1 blockade reduces interstitial inflammation and fibrosis in mice with glomerulosclerosis and nephrotic syndrome. V Vielhauer E Berning V Eis M Kretzler S Segerer F Strutz R Horuk HJ Grone D Schlondorff HJ Anders, Kidney Int 2004 66 6 2264 2278 10.1111/j.1523-1755.2004.66038.x 15569315
43. Age-related differences in adriamycin-induced nephropathy. H Hahn YS Park IS Ha HI Cheong Y Choi, Pediatr Nephrol 2004 19 7 761 766 10.1007/s00467-004- 1487-z 15138873
44. Serum- and glucocorticoid-inducible kinase 1 in doxorubicin-induced nephrotic syndrome. F Artunc O Nasir K Amann KM Boini HU Haring T Risler F Lang, Am J Physiol Renal Physiol 2008 295 6 1624 1634 10.1152/ajprenal.00032.2008 18768591